| Website | newlininvestment.com |
| Phone | 412-741-0630 |
| Employees | |
| Description | investment company |
Newlin Investment Company characterizes itself as a longer term investor based on specific performance goals to create substantial value for the company & the fund.
Capital investment in selected growth or value opportunities.
Develops strong partnership arrangement in working with companies.
Fund emphasizes fewer investments, rather than a broader portfolio.
Advisor to executives and boards on financial and business issues.
Hands-on involvement in developing strategic and business plans for companies ranging from industrial to retail to technology.
Building management teams from one-person start-up companies to larger, privately held companies.
Planning and executing an acquisition program.
Planning and executing a product licensing program.
| Company | Date | Round | Size | Participants |
| Carmell Therapeutics | 4/11 | Series A | $2.4M | 6 |
| Plextronics | 8/07 | Series B | $20.6M | 4 |